Curis
CRIS
#10347
Rank
ยฃ14.32 M
Marketcap
ยฃ0.37
Share price
-1.40%
Change (1 day)
-75.66%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -ยฃ24.78 Million

According to Curis's latest financial reports the company's current earnings are ยฃ11.65 Million. In 2024 the company made an earning of -ยฃ31.8 Million, an increase over its 2023 earnings that were of -ยฃ33.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ24.78 Million-22.08%
2024 -ยฃ31.8 Million-5.77%
2023 -ยฃ33.75 Million-13.1%
2022 -ยฃ38.84 Million27.52%
2021 -ยฃ30.46 Million65.09%
2020 -ยฃ18.45 Million-9.1%
2019 -ยฃ20.3 Million-4.73%
2018 -ยฃ21.3 Million-41.95%
2017 -ยฃ36.69 Million-14.37%
2016 -ยฃ42.85 Million3.55%
2015 -ยฃ41.38 Million271.52%
2014 -ยฃ11.14 Million76.64%
2013 -ยฃ6.31 Million
2011 -ยฃ5.36 Million27.76%
2010 -ยฃ4.2 Million-43.87%
2009 -ยฃ7.47 Million-23.44%
2008 -ยฃ9.76 Million56.66%
2007 -ยฃ6.23 Million-16.71%
2006 -ยฃ7.48 Million-36.92%
2005 -ยฃ11.85 Million156.25%
2004 -ยฃ4.63 Million-37.24%
2003 -ยฃ7.37 Million-93.34%
2002 -ยฃ0.12 Billion86.79%
2001 -ยฃ59.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ7.87 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.13 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-ยฃ46.01 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ0.74 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.22 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ18.41 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA